Healthcare
Coordination is the constraint, not capability.
Health systems do not typically suffer from a shortage of technology. They suffer from the cost of coordinating what they already have — across service lines that were acquired separately, clinical and administrative domains that follow different rules, and a change calendar set by clinical operations rather than by IT.
That is why the same EMR performs very differently in two organizations that bought the same licence. The variable is not the platform. It is how well the organization's decisions, data and workflow fit together around it.
Where the cost shows up
What makes healthcare different to work in
Three constraints change the shape of the work, and engagements that ignore them do not get delivered:
Clinical risk changes the adoption test. Approval turns on traceability, not accuracy alone. A recommendation that cannot be reconstructed is unusable regardless of how good it is.
Clinical and technical authority sit in different people. Governance has to work across both, and a design that has only satisfied IT has satisfied half the organization.
Change capacity is set by clinical operations. A technically sound sequence that ignores service-line reality is a sequence that slips.
How can a health system rationalize its technology portfolio?
By assessing applications against clinical and operational capabilities rather than against each other, reconciling discovery data with contract records and clinician interviews, and sequencing retirement against clinical dependencies. The sequencing constraint is stricter than in most sectors: a system whose data feeds a clinical workflow cannot be retired on a cost argument alone.
The method is set out in full under application rationalization, including why a portfolio decision decays and what it takes to keep it true.
How EXOS uses AI here
Inside the governance model rather than around it. AI drafts and surfaces; clinicians decide. Every output carries what informed it, who reviewed it, and what was AI-generated versus human-approved, and approval gates sit at thresholds defined before deployment. The knowledge AI reasons over carries explicit status, so an approved protocol is never weighted the same as a superseded draft — which is the most common cause of confident, fluent, wrong output.
Evidence
Healthlink Advisors, a 60+ person KLAS-ranked healthcare IT advisory firm, used institutional knowledge assetization to demonstrate acquisition-ready value. In October 2025 a larger healthcare consultancy of 1,450+ professionals acquired the firm to expand its enterprise resilience, technology implementation and identity management capabilities. It is the one publicly verifiable EXOS case, sourced to a press release linked from the case library.
Common questions
Does EXOS implement, or only advise?
Both. The enterprise architecture practice includes implementation services, and senior practitioners work alongside engineers, so the recommendation and the thing that delivers it arrive together.
Can AI recommendations be used in a clinical setting?
Only where they can be evidenced and a clinician approves. EXOS builds toward decision support with provenance and human approval, not autonomous clinical action.
What happens when the engagement ends?
You keep a governed environment your team can query: what was recommended, on what evidence, under what assumptions, and what changes if those assumptions move.